Dendritic cell differentiation and T-cell stimulatory function

Dendritic cell differentiation and T-cell stimulatory function refers to a complex biological process rather than a single molecular target. It encompasses the development of dendritic cells (DCs) from hematopoietic progenitors or monocytes and their subsequent maturation into potent antigen-presenting cells capable of activating naive T lymphocytes (Banchereau & Steinman, 1998, Nature). This process is fundamental to the initiation of adaptive immunity and involves the upregulation of major histocompatibility complex (MHC) molecules and costimulatory signals such as CD80 and CD86 (Mellman & Steinman, 2001, Cell). In a pharmacological context, this is often used as a phenotypic endpoint in assays designed to identify immunomodulators. Therapeutic strategies may aim to enhance this function to improve cancer immunosurveillance or suppress it to treat autoimmune diseases and prevent transplant rejection (Worbs et al., 2017, Nat Rev Immunol). Drugs affecting this process typically act on upstream receptors like FLT3 or GM-CSF receptors (e.g., sargramostim) or modulate costimulatory pathways (e.g., abatacept).

Other names

Dendritic cell maturationDC differentiationAntigen presentation processT-cell priming by dendritic cells

Modulation of hematopoietic differentiation pathways and costimulatory molecule expression to regulate the frequency, maturation state, and potency of antigen-presenting cells.